Unruptured Arteriovenous Malformations ; Do We Have an Answer After the Final Follow-Up of ARUBA? A Bayesian Viewpoint
Brain arteriovenous malformations (bAVMs) are vascular lesions that carry significant morbidity and mortality risk upon rupture. bAVM rupture causes either intracerebral or intraventricular hemorrhage, or both. In 2014, the first results of the ARUBA trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformations) were published in The Lancet , causing a paradigm shift in clinical practice and suggesting the superiority of medical treatment in terms of mortality or stroke compared with any intervention designed to obliterate the AVM. In 2020, the final results of the ARUBA trial were... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Reihe/Periodikum: | Stroke ; volume 52, issue 3, page 1143-1146 ; ISSN 0039-2499 1524-4628 |
Verlag/Hrsg.: |
Ovid Technologies (Wolters Kluwer Health)
|
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28866729 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1161/strokeaha.120.032429 |